|
93 Companies |
|
118 Products |
|
118 Products |
|
88 Mechanisms of Action |
|
3 Trials |
|
1622 News |
|
| «12345678910111213...3233» |
- Enrollment open, Trial primary completion date: Lactose-free Milk in Infants With Acute Diarrhea in a Developing Country (clinicaltrials.gov) - Jul 18, 2016
P=N/A, N=40, Recruiting, Sponsor: American University of Beirut Medical Center
Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2016 --> Jun 2017
- | megestrol / Generic mfg.
Trial completion: Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite (clinicaltrials.gov) - Jul 12, 2016
P3, N=429, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2016 --> Jun 2017 Active, not recruiting --> Completed
- | Trial completion: Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis (clinicaltrials.gov) - Jul 11, 2016
P3, N=130, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
Biomarker, Trial completion: Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy (clinicaltrials.gov) - Jul 4, 2016
P=N/A, N=308, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Active, not recruiting --> Completed No longer recruiting --> Completed
- | ondansetron / Generic mfg.
Trial completion, Metastases: Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment (clinicaltrials.gov) - Jul 4, 2016
P3, N=100, Completed, Sponsor: Alliance for Clinical Trials in Oncology
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Acupuncture in Infantile Colic - a Three Armed Randomized Multi Center Trial (ACU-COL) (clinicaltrials.gov) - Jun 29, 2016
P2/3, N=147, Completed, Sponsor: Lund University
Active, not recruiting --> Completed Recruiting --> Completed | N=192 --> 147
- Trial primary completion date: Lcr35 for Children With Functional Constipation (clinicaltrials.gov) - Jun 28, 2016
P4, N=94, Recruiting, Sponsor: Medical University of Warsaw
Recruiting --> Completed | N=192 --> 147 Trial primary completion date: Jun 2016 --> Nov 2016
- Enrollment closed, Enrollment change, Trial primary completion date: Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo (clinicaltrials.gov) - Jun 27, 2016
P=N/A, N=22, Active, not recruiting, Sponsor: Yale University
Trial primary completion date: Jun 2016 --> Nov 2016 Recruiting --> Active, not recruiting | N=50 --> 22 | Trial primary completion date: Apr 2016 --> Sep 2016
- Trial completion, Trial primary completion date: CBT4BN: Online Cognitive Behavioral Therapy for Bulimia Nervosa (clinicaltrials.gov) - Jun 23, 2016
P=N/A, N=196, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting | N=50 --> 22 | Trial primary completion date: Apr 2016 --> Sep 2016 Active, not recruiting --> Completed | Trial primary completion date: Jan 2016 --> May 2016
- Enrollment closed: Guided Self-help for Binge Eating (clinicaltrials.gov) - Jun 21, 2016
P=N/A, N=102, Active, not recruiting, Sponsor: Oxford Health NHS Foundation Trust
Active, not recruiting --> Completed | Trial primary completion date: Jan 2016 --> May 2016 Recruiting --> Active, not recruiting
- Trial primary completion date: Screening for Fabry Disease in a Pediatric Population at Risk (clinicaltrials.gov) - Jun 21, 2016
P=N/A, N=2000, Recruiting, Sponsor: University Hospital Heidelberg
Recruiting --> Active, not recruiting Trial primary completion date: Jul 2015 --> Dec 2016
- Trial completion: Comparing the Effectiveness of Three Types of Therapy for the Treatment of Anorexia Nervosa in Adolescents (clinicaltrials.gov) - Jun 21, 2016
P2, N=121, Completed, Sponsor: University of Chicago
Trial primary completion date: Jul 2015 --> Dec 2016 Active, not recruiting --> Completed
- morphine sulphate / Generic mfg.
Trial completion, Trial initiation date, Trial primary completion date: AcuMoPE: Acupuncture Versus IV Morphine in the Treatment of Acute Pain in ED (clinicaltrials.gov) - Jun 20, 2016
P0, N=100, Completed, Sponsor: University of Monastir
Active, not recruiting --> Completed Recruiting --> Completed | Initiation date: Sep 2013 --> Apr 2012 | Trial primary completion date: Sep 2014 --> Apr 2013
- |||| Trial completion: Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation (clinicaltrials.gov) - Jun 10, 2016
P2, N=192, Completed, Sponsor: KGK Synergize Inc.
Recruiting --> Completed | Initiation date: Sep 2013 --> Apr 2012 | Trial primary completion date: Sep 2014 --> Apr 2013 Recruiting --> Completed
- ||||| Aemcolo (rifamycin SV MMX) / Cosmo Pharma, RedHill, Dr Falk
Enrollment closed, Trial primary completion date: ERASE: Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea (clinicaltrials.gov) - Jun 2, 2016
P3, N=776, Active, not recruiting, Sponsor: Dr. Falk Pharma GmbH
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Apr 2016
- Trial initiation date, Trial termination: Modified Functional Magnetic Stimulation Treatment for Constipation Improvement (clinicaltrials.gov) - May 28, 2016
P=N/A, N=140, Terminated, Sponsor: Taipei Medical University WanFang Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Apr 2016 Initiation date: Jan 2011 --> Jun 2011 | Active, not recruiting --> Terminated; no sufficient subjects
- aprepitant oral / Generic mfg.
Enrollment open: Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents (clinicaltrials.gov) - May 27, 2016
P2, N=22, Recruiting, Sponsor: The Hospital for Sick Children
Initiation date: Jan 2011 --> Jun 2011 | Active, not recruiting --> Terminated; no sufficient subjects Suspended --> Recruiting
- Trial completion, HEOR: Medico-economic Evaluation of ENTERRA Therapy (clinicaltrials.gov) - May 27, 2016
P=N/A, N=220, Completed, Sponsor: University Hospital, Rouen
Suspended --> Recruiting Active, not recruiting --> Completed
- Trial primary completion date: STIMOREX: rTMS and Body Shape Perception (clinicaltrials.gov) - May 26, 2016
P=N/A, N=54, Recruiting, Sponsor: University Hospital, Rouen
Active, not recruiting --> Completed Trial primary completion date: May 2016 --> Nov 2016
- Trial completion: Motivating Factors That Play a Role in Bulimia Nervosa (clinicaltrials.gov) - May 25, 2016
P=N/A, N=90, Completed, Sponsor: New York State Psychiatric Institute
Trial primary completion date: May 2016 --> Nov 2016 Active, not recruiting --> Completed
- | Ibodutant (MEN 15596) / Menarini
Trial termination: IRIS-4: 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (clinicaltrials.gov) - May 19, 2016
P3, N=500, Terminated, Sponsor: Menarini Group
Active, not recruiting --> Completed Active, not recruiting --> Terminated; Because of negative results of the sister study NAK-06 and the low overall response rate at week 24.
- Ibodutant (MEN 15596) / Menarini
Enrollment change, Trial withdrawal: IRIS-05: 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (clinicaltrials.gov) - May 19, 2016
P3, N=0, Withdrawn, Sponsor: Menarini Group
Active, not recruiting --> Terminated; Because of negative results of the sister study NAK-06 and the low overall response rate at week 24. N=500 --> 0 | Suspended --> Withdrawn
- Trial completion, Enrollment change, Trial initiation date: Engaging Latino Families in Eating Disorders Treatment (clinicaltrials.gov) - May 19, 2016
P=N/A, N=25, Completed, Sponsor: Mae Lynn Reyes-Rodriguez, PhD
N=500 --> 0 | Suspended --> Withdrawn Active, not recruiting --> Completed | N=40 --> 25 | Initiation date: Oct 2012 --> Aug 2010
- | Trial completion: The Effects of a Ficus Carica in Subjects With Functional Constipation (clinicaltrials.gov) - May 17, 2016
P2/3, N=80, Completed, Sponsor: Chonbuk National University Hospital
Active, not recruiting --> Completed | N=40 --> 25 | Initiation date: Oct 2012 --> Aug 2010 Recruiting --> Completed
- Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
Trial primary completion date: Efficacy of Rifaximin in Preventing Campylobacteriosis (clinicaltrials.gov) - May 14, 2016
P2/3, N=28, Active, not recruiting, Sponsor: Johns Hopkins Bloomberg School of Public Health
Recruiting --> Completed Trial primary completion date: Jun 2015 --> Jun 2016
- Trial primary completion date: PIM: Pediatric Integrative Medicine Trial Pilot (clinicaltrials.gov) - May 14, 2016
P3, N=200, Active, not recruiting, Sponsor: University of Alberta
Trial primary completion date: Jun 2015 --> Jun 2016 Trial primary completion date: Sep 2015 --> Feb 2016
- Biomarker, Trial completion, Trial primary completion date: Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic (clinicaltrials.gov) - May 13, 2016
P1, N=21, Completed, Sponsor: The University of Texas Health Science Center, Houston
Trial primary completion date: Sep 2015 --> Feb 2016 Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Apr 2016
- dexamethasone / Generic mfg., olanzapine / Generic mfg., metoclopramide / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: COMFORT: Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis (clinicaltrials.gov) - May 11, 2016
P2, N=23, Terminated, Sponsor: Karin Jordan
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Apr 2016 N=86 --> 23 | Recruiting --> Terminated | Trial primary completion date: Dec 2011 --> Oct 2013; poor enrolment
- ||||||| Symproic (naldemedine) / Shionogi, Collegium Pharma
Trial completion: Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation (clinicaltrials.gov) - May 9, 2016
P3, N=540, Completed, Sponsor: Shionogi
N=86 --> 23 | Recruiting --> Terminated | Trial primary completion date: Dec 2011 --> Oct 2013; poor enrolment Active, not recruiting --> Completed
- Trial termination, Head-to-Head: Low Dose Versus Usual Dose Dexamethasone for Symptom Control in Children Undergoing Cranial or Craniospinal Radiation (clinicaltrials.gov) - May 6, 2016
P3, N=25, Terminated, Sponsor: The Hospital for Sick Children
Active, not recruiting --> Completed Active, not recruiting --> Terminated; premature closure due to lack of accrual
- amitriptyline / Generic mfg.
Trial primary completion date: The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS) (clinicaltrials.gov) - May 4, 2016
P=N/A, N=500, Enrolling by invitation, Sponsor: Medical College of Wisconsin
Active, not recruiting --> Terminated; premature closure due to lack of accrual Trial primary completion date: Jan 2016 --> Dec 2016
- loperamide / Generic mfg.
Trial suspension, Trial primary completion date: Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy (clinicaltrials.gov) - May 4, 2016
P4, N=120, Suspended, Sponsor: VA Medical Center, Houston
Trial primary completion date: Jan 2016 --> Dec 2016 Recruiting --> Suspended | Trial primary completion date: Dec 2009 --> Dec 2013
- |||| cadazolid (ACT-179811) / J&J
Trial primary completion date: Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea (clinicaltrials.gov) - May 2, 2016
P3, N=640, Recruiting, Sponsor: Actelion
Recruiting --> Suspended | Trial primary completion date: Dec 2009 --> Dec 2013 Trial primary completion date: Jun 2016 --> Dec 2016
- |||| cadazolid (ACT-179811) / J&J
Trial primary completion date: Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (clinicaltrials.gov) - May 2, 2016
P3, N=640, Recruiting, Sponsor: Actelion
Trial primary completion date: Jun 2016 --> Dec 2016 Trial primary completion date: Jun 2016 --> Feb 2017
- | Trial termination, Trial primary completion date: Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II) (clinicaltrials.gov) - May 2, 2016
P2, N=120, Terminated, Sponsor: Nutrabiotix, LLC
Trial primary completion date: Jun 2016 --> Feb 2017 Recruiting --> Terminated | Trial primary completion date: Jul 2015 --> Apr 2016; Per DSMB, study fiber had given subjects more adverse events and made their IBS symptoms worse than the psyllium group.
- ondansetron / Generic mfg.
Phase classification, Trial primary completion date: OSEP: Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan (clinicaltrials.gov) - Apr 22, 2016
P4, N=868, Recruiting, Sponsor: Sarah Williamson-Urquhart
Recruiting --> Terminated | Trial primary completion date: Jul 2015 --> Apr 2016; Per DSMB, study fiber had given subjects more adverse events and made their IBS symptoms worse than the psyllium group. Phase classification: P3 --> P4 | Trial primary completion date: Aug 2016 --> Aug 2018
- ondansetron / Generic mfg.
Phase classification, Trial primary completion date: OWEP: Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan (clinicaltrials.gov) - Apr 22, 2016
P4, N=602, Recruiting, Sponsor: Sarah Williamson-Urquhart
Phase classification: P3 --> P4 | Trial primary completion date: Aug 2016 --> Aug 2018 Phase classification: P3 --> P4 | Trial primary completion date: Aug 2016 --> Nov 2016
- mizagliflozin (VGX-3235) / Vogenx
Trial completion, Trial primary completion date: Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC) (clinicaltrials.gov) - Apr 18, 2016
P2, N=0, Completed, Sponsor: Kissei Pharmaceutical Co., Ltd.
Phase classification: P3 --> P4 | Trial primary completion date: Aug 2016 --> Nov 2016 Recruiting --> Completed | Trial primary completion date: Oct 2015 --> May 2015
- mizagliflozin (VGX-3235) / Vogenx
Trial completion, Trial primary completion date: Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC) (clinicaltrials.gov) - Apr 18, 2016
P2, N=0, Completed, Sponsor: Kissei Pharmaceutical Co., Ltd.
Recruiting --> Completed | Trial primary completion date: Oct 2015 --> May 2015 Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Apr 2015
- Trial completion: Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail (clinicaltrials.gov) - Apr 15, 2016
P=N/A, N=39, Completed, Sponsor: Beijing University of Chinese Medicine
Recruiting --> Completed | Trial primary completion date: Oct 2015 --> Apr 2015 Recruiting --> Completed
- Trial completion: Adaptive Family Treatment for Adolescent Anorexia Nervosa (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=90, Completed, Sponsor: Stanford University
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: EFI: Cognitive Behaviour Therapy for Patients With IBS (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=100, Completed, Sponsor: Rabin Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Completed
- Trial completion: Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa (clinicaltrials.gov) - Apr 8, 2016
P=N/A, N=50, Completed, Sponsor: New York State Psychiatric Institute
Not yet recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=144, Completed, Sponsor: Vibrant Ltd.
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: Managing Recurrent Abdominal Pain (clinicaltrials.gov) - Apr 1, 2016
P2, N=200, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed Recruiting --> Completed
- Trial termination, Trial primary completion date: Kappa Opioid Receptor Imaging in Anorexia (clinicaltrials.gov) - Mar 31, 2016
P=N/A, N=7, Terminated, Sponsor: New York University School of Medicine
Active, not recruiting --> Terminated | Trial primary completion date: Mar 2015 --> Mar 2016; The original PI, Alexander Neumeister, left NYULMC. No data was analyzed.
- Enrollment closed: A Randomized-controlled Study of a Cognitive-behavioral Intervention for Children With Functional Abdominal Pain (clinicaltrials.gov) - Mar 25, 2016
P=N/A, N=127, Active, not recruiting, Sponsor: University of Potsdam
No data was analyzed. Recruiting --> Active, not recruiting
- Trial completion: Stress and Eating Study (clinicaltrials.gov) - Mar 24, 2016
P=N/A, N=154, Completed, Sponsor: VA Office of Research and Development
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Trial completion: Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain (clinicaltrials.gov) - Mar 23, 2016
P2, N=254, Completed, Sponsor: Forest Laboratories
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Trial initiation date, Trial primary completion date: Effect of Probiotics in Childhood Abdominal Pain (clinicaltrials.gov) - Mar 23, 2016
P=N/A, N=101, Completed, Sponsor: Soroka University Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Completed | Initiation date: Jan 2013 --> Mar 2011 | Trial primary completion date: Dec 2015 --> Oct 2013